Paper Details

Paper Title

Latent EBV impairs immune cell signaling and enhances the efficacy of anti-CD3 mAb in Type 1 Diabetes.

Paper Journal Title

medRxiv

Paper Citation Count

Paper Publication Year

2023

Bio Mention

CD8, CD8 T cells, EBV, T cell receptor, Tregs, Type 1 Diabetes, adaptive, adaptive immune cells, anti-CD3 mAb, immune cell, immune cells, patients, peripheral blood cells, teplizumab, type 1 diabetes

Mesh Descriptor

Paper Details

Column Actions

Datasets